Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa

Objectives: To investigate the prevalence of high-risk (HR) human papillomavirus (HPV) and factors associated with HR-HPV infection among women from rural Eastern Cape, South Africa. Methods: HPV prevalence was determined by Hybrid Capture 2 assay in cervical specimens from 417 women aged ≥30 years...

Full description

Bibliographic Details
Main Authors: Ongeziwe Taku, Charles B. Businge, Mana L. Mdaka, Keletso Phohlo, Wisdom Basera, Mirta Garcia-Jardon, Tracy L. Meiring, Ulf Gyllensten, Anna-Lise Williamson, Zizipho Z.A. Mbulawa
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220301090
_version_ 1818243368610693120
author Ongeziwe Taku
Charles B. Businge
Mana L. Mdaka
Keletso Phohlo
Wisdom Basera
Mirta Garcia-Jardon
Tracy L. Meiring
Ulf Gyllensten
Anna-Lise Williamson
Zizipho Z.A. Mbulawa
author_facet Ongeziwe Taku
Charles B. Businge
Mana L. Mdaka
Keletso Phohlo
Wisdom Basera
Mirta Garcia-Jardon
Tracy L. Meiring
Ulf Gyllensten
Anna-Lise Williamson
Zizipho Z.A. Mbulawa
author_sort Ongeziwe Taku
collection DOAJ
description Objectives: To investigate the prevalence of high-risk (HR) human papillomavirus (HPV) and factors associated with HR-HPV infection among women from rural Eastern Cape, South Africa. Methods: HPV prevalence was determined by Hybrid Capture 2 assay in cervical specimens from 417 women aged ≥30 years (median 46 years) recruited from the community health clinic in the Eastern Cape. Results: HR-HPV prevalence was 28.5% (119/417), and HIV-positive women had significantly higher HR-HPV prevalence than HIV-negative women (40.6%, 63/155 vs 21.4%, 56/262, respectively; p = 0.001). HIV-positive status (odds ratio (OR) 2.52, 95% confidence interval (CI) 1.63–3.90), having ≥3 lifetime sexual partners (OR 2.12, 95% CI 1.16–3.89), having ≥1 sexual partner in the last month (OR 1.89, 95% CI 1.21–2.92), ≥4 times frequency of vaginal sex in the past 1 month (OR 2.40, 95% CI 1.32–4.35), and having a vaginal discharge currently/in the previous week (OR 2.13, 95% CI 1.18–3.85) increased the risk of HR-HPV infection. In the multivariate analysis, HIV positivity remained strongly associated with HR-HPV infection (OR 1.94, 95% CI 1.17–3.22). Conclusions: Risk factors related to sexual behaviors play a significant role in HR-HPV infection in this population. This report will inform health policymakers on HPV prevalence and contribute to discussions on the use of HPV testing as the primary cervical cancer screening test in South Africa.
first_indexed 2024-12-12T14:00:01Z
format Article
id doaj.art-9055bf16fdfd49569a6a7e15dc7b9105
institution Directory Open Access Journal
issn 1201-9712
language English
last_indexed 2024-12-12T14:00:01Z
publishDate 2020-06-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-9055bf16fdfd49569a6a7e15dc7b91052022-12-22T00:22:23ZengElsevierInternational Journal of Infectious Diseases1201-97122020-06-0195176182Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South AfricaOngeziwe Taku0Charles B. Businge1Mana L. Mdaka2Keletso Phohlo3Wisdom Basera4Mirta Garcia-Jardon5Tracy L. Meiring6Ulf Gyllensten7Anna-Lise Williamson8Zizipho Z.A. Mbulawa9Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South AfricaDepartment of Obstetrics and Gynaecology, Nelson Mandela Academic Hospital, Mthatha, South Africa; Department of Obstetrics and Gynaecology, Faculty of Health Sciences, Walter Sisulu University, Mthatha, South AfricaDepartment of Obstetrics and Gynaecology, Nelson Mandela Academic Hospital, Mthatha, South Africa; Department of Obstetrics and Gynaecology, Faculty of Health Sciences, Walter Sisulu University, Mthatha, South AfricaDivision of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South AfricaSchool of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South AfricaDepartment of Pathology at Walter Sisulu University and National Health Laboratory Service, Mthatha, South AfricaDivision of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South AfricaDepartment of Immunology, Genetics, and Pathology, Biomedical Centre, Science for Life Laboratory, Uppsala University, Uppsala, SwedenDivision of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; SAMRC Gynaecological Cancer Research Centre, University of Cape Town, Cape Town, South AfricaDivision of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; SAMRC Gynaecological Cancer Research Centre, University of Cape Town, Cape Town, South Africa; Centre for HIV and STIs, National Institute for Communicable Diseases, NHLS, Groote Schuur Hospital, Cape Town, South Africa; Department of Laboratory Medicine and Pathology, Faculty of Health Sciences, Walter Sisulu University, Mthatha, South Africa; National Health Laboratory Service, Nelson Mandela Academic Hospital, Mthatha, South Africa; Corresponding author at: Department of Laboratory Medicine and Pathology, National Health Laboratory Service and Walter Sisulu University, Nelson Mandela Academic Hospital, Fort Gale, Mthatha, South Africa.Objectives: To investigate the prevalence of high-risk (HR) human papillomavirus (HPV) and factors associated with HR-HPV infection among women from rural Eastern Cape, South Africa. Methods: HPV prevalence was determined by Hybrid Capture 2 assay in cervical specimens from 417 women aged ≥30 years (median 46 years) recruited from the community health clinic in the Eastern Cape. Results: HR-HPV prevalence was 28.5% (119/417), and HIV-positive women had significantly higher HR-HPV prevalence than HIV-negative women (40.6%, 63/155 vs 21.4%, 56/262, respectively; p = 0.001). HIV-positive status (odds ratio (OR) 2.52, 95% confidence interval (CI) 1.63–3.90), having ≥3 lifetime sexual partners (OR 2.12, 95% CI 1.16–3.89), having ≥1 sexual partner in the last month (OR 1.89, 95% CI 1.21–2.92), ≥4 times frequency of vaginal sex in the past 1 month (OR 2.40, 95% CI 1.32–4.35), and having a vaginal discharge currently/in the previous week (OR 2.13, 95% CI 1.18–3.85) increased the risk of HR-HPV infection. In the multivariate analysis, HIV positivity remained strongly associated with HR-HPV infection (OR 1.94, 95% CI 1.17–3.22). Conclusions: Risk factors related to sexual behaviors play a significant role in HR-HPV infection in this population. This report will inform health policymakers on HPV prevalence and contribute to discussions on the use of HPV testing as the primary cervical cancer screening test in South Africa.http://www.sciencedirect.com/science/article/pii/S1201971220301090High-risk human papillomavirusPrevalenceRisk factorsHIVSouth African women
spellingShingle Ongeziwe Taku
Charles B. Businge
Mana L. Mdaka
Keletso Phohlo
Wisdom Basera
Mirta Garcia-Jardon
Tracy L. Meiring
Ulf Gyllensten
Anna-Lise Williamson
Zizipho Z.A. Mbulawa
Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa
International Journal of Infectious Diseases
High-risk human papillomavirus
Prevalence
Risk factors
HIV
South African women
title Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa
title_full Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa
title_fullStr Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa
title_full_unstemmed Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa
title_short Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa
title_sort human papillomavirus prevalence and risk factors among hiv negative and hiv positive women residing in rural eastern cape south africa
topic High-risk human papillomavirus
Prevalence
Risk factors
HIV
South African women
url http://www.sciencedirect.com/science/article/pii/S1201971220301090
work_keys_str_mv AT ongeziwetaku humanpapillomavirusprevalenceandriskfactorsamonghivnegativeandhivpositivewomenresidinginruraleasterncapesouthafrica
AT charlesbbusinge humanpapillomavirusprevalenceandriskfactorsamonghivnegativeandhivpositivewomenresidinginruraleasterncapesouthafrica
AT manalmdaka humanpapillomavirusprevalenceandriskfactorsamonghivnegativeandhivpositivewomenresidinginruraleasterncapesouthafrica
AT keletsophohlo humanpapillomavirusprevalenceandriskfactorsamonghivnegativeandhivpositivewomenresidinginruraleasterncapesouthafrica
AT wisdombasera humanpapillomavirusprevalenceandriskfactorsamonghivnegativeandhivpositivewomenresidinginruraleasterncapesouthafrica
AT mirtagarciajardon humanpapillomavirusprevalenceandriskfactorsamonghivnegativeandhivpositivewomenresidinginruraleasterncapesouthafrica
AT tracylmeiring humanpapillomavirusprevalenceandriskfactorsamonghivnegativeandhivpositivewomenresidinginruraleasterncapesouthafrica
AT ulfgyllensten humanpapillomavirusprevalenceandriskfactorsamonghivnegativeandhivpositivewomenresidinginruraleasterncapesouthafrica
AT annalisewilliamson humanpapillomavirusprevalenceandriskfactorsamonghivnegativeandhivpositivewomenresidinginruraleasterncapesouthafrica
AT ziziphozambulawa humanpapillomavirusprevalenceandriskfactorsamonghivnegativeandhivpositivewomenresidinginruraleasterncapesouthafrica